GlassScriptPhysician profile
Shauna Johnson
NPI 1366933558
$4,151.98
in general payments reported to CMS, 2019-2025
15 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $914 · 2022: $346 · 2023: $1,643 · 2024: $1,043 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,851 · Education: $40.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,851.06 |
| Education | $40.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $727.65 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $575.83 | 2021-2024 | Uzedy, Austedo Xr, Austedo |
| Abbvie INC. | $564.33 | 2021-2024 | |
| Indivior INC. | $409.77 | 2021-2024 | Perseris |
| Janssen Pharmaceuticals, INC | $375.43 | 2021-2025 | Invega Sustenna |
| Neurocrine Biosciences, INC. | $356.62 | 2021-2024 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $323.53 | 2021-2024 | Caplyta |
| Lundbeck LLC | $222.19 | 2021-2024 | Rexulti, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $200.74 | 2021-2025 | Fanapt, Hetlioz |
| Alkermes, INC. | $128.27 | 2021-2024 | Aristada, Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $109.25 | 2024-2025 | Cobenfy |
| Sunovion Pharmaceuticals INC. | $73.63 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $37.93 | 2024 | Qelbree |
| Axsome Therapeutics, INC. | $33.21 | 2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $13.60 | 2023 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shauna Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.